NEW YORK (GenomeWeb) – Biodesix said today it has entered a collaboration agreement with Chinese life sciences firm Bioyong Technology to develop and commercialize Biodesix's Veristrat test for clinical use in China.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.